Advertisement
Organisation › Details
Blueprint Genetics Oy
Blueprint Genetics is one of the fastest growing genetic testing businesses globally in the field of clinical genetic testing of rare inherited diseases. With a patient centered mindset, the company was founded in 2012 and has since been on a mission to bring world-class genetic knowledge to mainstream healthcare with four guiding principles: innovation, transparency, quality and accessibility. The company is based in Helsinki and Seattle, with a customer base spanning over 70 countries. *
Start | 2012-01-01 established | |
Group | Quest Diagnostics (Group) | |
Industry | clinical genomic test (nucleic acid diagnostics) | |
Industry 2 | CLINT artificial intelligence platform | |
Person | Lehtonen, Tommi (Hedera Dx 202209 CEO + +Co-Founder before Blueprint Genetics 201707 CEO) | |
Region | Espoo | |
Country | Finland | |
Street | 16 A-B Keilaranta | |
City | 02150 Espoo | |
Tel | +358-40-1662-153 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Blueprint Genetics Oy. (9/24/19). "Press Release: Blueprint Genetics and ArchimedLife Form a Partnership to Launch High Quality Biochemical Testing for Rare Diseases in North America". | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Quest Diagnostics (Group)
- [1] Blueprint Genetics Oy. (1/22/20). "Press Release: Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases"....
- [2] BC Platforms AG. (10/17/19). "Press Release: BC Platforms Partners with Blueprint Genetics to Provide Center of Excellence for Data Driven Testing Services in Rare Diseases". Zürich & Boston, MA....
- [3] Blueprint Genetics Oy. (10/2/19). "Press Release: Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness Launch an Open Access Program for Patients with Inherited Retinal Disease in the United States"....
- [4] Blueprint Genetics Oy. (9/24/19). "Press Release: Blueprint Genetics and ArchimedLife Form a Partnership to Launch High Quality Biochemical Testing for Rare Diseases in North America"....
- [5] Creathor Venture Management GmbH. (7/11/17). "Press Release: Creathor Venture Invests in AI-enabled Clinical Genetic Testing Company Blueprint Genetics as Part of an up to EUR 14 Million Financing Round". Bad Homburg v. d. H.....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top